Cost effectiveness analysis of tuberculosis control policies (in Invanovo Oblast, Russian Federation)

被引：0
|
作者：
机构：
来源：
The Indian Journal of Pediatrics | 1999年 / 66卷 / 2期
关键词：
Lupus Nephritis; Fourth SCenario; Current Tuberculosis; Short Regimen; Individualize Treatment Regimen;
D O I：
10.1007/BF02761213
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：223 / 223
相关论文
共 50 条
  • [21] Tobacco control in the Russian Federation- a policy analysis
    Lunze, Karsten
    Migliorini, Luigi
    BMC PUBLIC HEALTH, 2013, 13
  • [22] Cost-Effectiveness Analysis of Interventions for Tuberculosis Control: DALYs Versus QALYs
    Diel, R.
    Lampenius, N.
    PHARMACOECONOMICS, 2014, 32 (07) : 617 - 626
  • [23] Cost-Effectiveness Analysis of Interventions for Tuberculosis Control: DALYs Versus QALYs
    R. Diel
    N. Lampenius
    PharmacoEconomics, 2014, 32 : 617 - 626
  • [24] Cost-effectiveness of novel vaccines for tuberculosis control: a decision analysis study
    Chia-Lin Tseng
    Olivia Oxlade
    Dick Menzies
    Anne Aspler
    Kevin Schwartzman
    BMC Public Health, 11
  • [25] Cost-effectiveness of novel vaccines for tuberculosis control: a decision analysis study
    Tseng, Chia-Lin
    Oxlade, Olivia
    Menzies, Dick
    Aspler, Anne
    Schwartzman, Kevin
    BMC PUBLIC HEALTH, 2011, 11
  • [26] Cost minimization analysis of line probe assay for detection of multidrug-resistant tuberculosis in Arkhangelsk region of Russian Federation
    Bogdanova, E. N.
    Mariandyshev, A. O.
    Balantcev, G. A.
    Eliseev, P. I.
    Nikishova, E. I.
    Gaida, A. I.
    Enarson, D.
    Detjen, A.
    Dacombe, R.
    Phillips, P. P. J.
    Squire, S. B.
    Gospodarevskaya, E.
    PLOS ONE, 2019, 14 (01):
  • [27] THE COST-EFFECTIVENESS OF QUETIAPINE, ARIPIPRAZOLE OR OLANZAPINE IN PATIENTS WITH BIPOLAR DEPRESSION IN THE RUSSIAN FEDERATION
    Kulikov, A.
    Komarov, I
    VALUE IN HEALTH, 2013, 16 (03) : A62 - A62
  • [28] COST-EFFECTIVENESS AND BUDGET IMPACT ANALYSIS OF NILOTINIB FOR THE SECOND LINE TRATMENT OF CHRONIC MIELOID LEUKEMIA IN THE RUSSIAN FEDERATION
    Avxentyev, N. A.
    Frolov, M. Y.
    Makarov, A. S.
    VALUE IN HEALTH, 2018, 21 : S29 - S29
  • [29] COST ANALYSIS IN THE TREATMENT OF PATIENTS WITH SYSTEMIC LUPUS ERYTHEMATOSUS IN RUSSIAN FEDERATION
    Kulikov, A.
    Komarov, I
    Pochuprina, A.
    VALUE IN HEALTH, 2014, 17 (07) : A527 - A527
  • [30] COST-EFFECTIVENESS ANALYSIS OF CANACINUMAB IN THE TREATMENT OF PATIENTS SUFFERING FROM SYSTEMIC JUVENILE IDIOPATHIC ARTHRITIS IN RUSSIAN FEDERATION
    Yagudina, R.
    Kulikov, A.
    Pochuprina, A.
    VALUE IN HEALTH, 2015, 18 (07) : A646 - A646
12345